Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
Nghiemphu PL, Wen PY, Lamborn KR, Drappatz J, Robins HI, Fink K, Malkin MG, Lieberman FS, DeAngelis LM, Torres-Trejo A, Chang SM, Abrey L, Fine HA, Demopoulos A, Lassman AB, Kesari S, Mehta MP, Prados MD, Cloughesy TF; North American Brain Tumor Consortium. Nghiemphu PL, et al. Among authors: demopoulos a. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1422-7. doi: 10.1016/j.ijrobp.2010.07.1997. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20934264 Free PMC article. Clinical Trial.
Salvage temozolomide for prior temozolomide responders.
Franceschi E, Omuro AM, Lassman AB, Demopoulos A, Nolan C, Abrey LE. Franceschi E, et al. Among authors: demopoulos a. Cancer. 2005 Dec 1;104(11):2473-6. doi: 10.1002/cncr.21564. Cancer. 2005. PMID: 16270316 Free article.
Neurologic complications of leukemia.
Demopoulos A, DeAngelis LM. Demopoulos A, et al. Curr Opin Neurol. 2002 Dec;15(6):691-9. doi: 10.1097/01.wco.0000044765.39452.2d. Curr Opin Neurol. 2002. PMID: 12447107 Review.
Sequencing and curation strategies for identifying candidate glioblastoma treatments.
Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Geiger H, Felice V, Dikoglu E, Rahman S, Fang A, Vacic V, Bergmann EA, Vogel JLM, Reeves C, Khaira D, Calabro A, Kim D, Lamendola-Essel MF, Esteves C, Agius P, Stolte C, Boockvar J, Demopoulos A, Placantonakis DG, Golfinos JG, Brennan C, Bruce J, Lassman AB, Canoll P, Grommes C, Daras M, Diamond E, Omuro A, Pentsova E, Orange DE, Harvey SJ, Posner JB, Michelini VV, Jobanputra V, Zody MC, Kelly J, Parida L, Wrzeszczynski KO, Royyuru AK, Darnell RB. Frank MO, et al. Among authors: demopoulos a. BMC Med Genomics. 2019 Apr 25;12(1):56. doi: 10.1186/s12920-019-0500-0. BMC Med Genomics. 2019. PMID: 31023376 Free PMC article.
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
Chakraborty S, Filippi CG, Wong T, Ray A, Fralin S, Tsiouris AJ, Praminick B, Demopoulos A, McCrea HJ, Bodhinayake I, Ortiz R, Langer DJ, Boockvar JA. Chakraborty S, et al. Among authors: demopoulos a. J Neurooncol. 2016 Jul;128(3):405-15. doi: 10.1007/s11060-016-2099-8. Epub 2016 Mar 5. J Neurooncol. 2016. PMID: 26945581 Clinical Trial.
45 results